State Pharmacy Forum Being Held at TUC on Sept. 23
All seven Ohio Colleges of Pharmacyincluding the University of Cincinnati (UC), Ohio Northern University, Ohio State University, University of Toledo, University of Findlay, Northeast Ohio Medical University and Cedarville Universitywill be represented at the 2nd Ohio Pharmacy Forum hosted by UC from 7:30 a.m. to 1:30 p.m. Friday, Sept. 23, in Tangeman University Centers Great Hall.
The forum is presented by state organizations to include the Ohio College of Clinical Pharmacy (OCCP), the Ohio Society of Health-System Pharmacists, the Ohio Pharmacists Association and the Council for Ohio Health Care Advocacy.
It provides a venue for Ohio pharmacists from various practice areas (hospital, community pharmacy and academia) to discuss current national and state legislation influencing the profession of pharmacy and to engage with state lawmakers who serve in the forefront of these changes. The forum also offers an opportunity for networking between the colleges and state organizations.
Additionally, Professor Don Downing from the University of Washington will present on the Washington state experience with pharmacists as providers. Senior Vice President of Pharmacy Practice and Government Affairs at the American Pharmacists Association Stacie Maass will review national pharmacy advocacy updates.
To close the forum, the OCCP Legislator of the Year Award will be presented at noon. This years award is being presented to Senator Dave Burke (R), Ohio Senate District 26. The presentation and Burkes remarks begin at 11:45 a.m.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.